Similar Items: Real‐world pharmacovigilance for anti‐Aβ therapies using a large language model
- Preparedness and quality of dementia care in an Italian health authority when introducing anti‐Aβ therapies
- Clinical and MRI features associated with amyloid positivity in secondary screening for anti–amyloid‐β therapy
- From clinical trial to clinical experience: Lecanemab therapy in a real‐world case series
- Real‐world use of lecanemab: patient pathway findings from a US multicenter study
- Variable Aβ tracer uptake in hyperostosis frontalis interna: implications for brain Aβ PET/CT interpretation
- White matter hyperintensities in Alzheimer's disease in the era of anti‐amyloid therapies